Nasus Pharma Ltd. (NSRX) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

Nasus Pharma Ltd. (NSRX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $26.0M, listed on AMEX, employing roughly 2 people, carrying a beta of 3.89 to the broader market. Nasus Pharma is a clinical-stage specialty pharmaceutical company focused primarily on the development of intranasal drugs to treat emergency medical conditions such as severe allergies, anaphylaxis, and opioid overdose. Led by Dan Teleman, public since 2025-08-13.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for NSRX as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →